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Abstract.  A  90-kD lymphocyte surface glycoprotein, 
defined by monoclonal antibodies of the Hermes se- 
ties,  is involved in lymphocyte recognition of high en- 
dothelial venules (HEV).  Lymphocyte gp90  H'~s binds 
in a  saturable,  reversible fashion to the mucosal vascu- 
lar addressin (MAd), a tissue-specific endothelial cell 
adhesion molecule for lymphocytes. We and others 
have recently shown that the Hermes antigen  is identi- 
cal to or includes CD44 (In[Lu]-related p80), human 
Pgp-1,  and extracellular matrix receptor HI-molecules 
reportedly expressed on diverse cell types. Here, we 
examine the relationship between lymphoid and non- 
lymphoid Hermes antigens using serologic, biochemi- 
cal, and,  most importantly,  functional assays. Consis- 
tent with studies using mAbs to CD44 or Pgp-1,  rnAbs 
against five different epitopes on lymphocyte gp90  H  .... 
reacted with a  wide variety of nonhematolymphoid 
cells in diverse normal human tissues,  including many 
types of epithelium,  mesenchymal elements such as 
fibroblasts and smooth muscle, and a  subset of glia in 
the central nervous system. To ask whether these non- 
lymphoid molecules might also be functionally homol- 
ogous to lymphocyte homing receptors,  we assessed 
their ability to interact  with purified MAd using 
fluorescence energy transfer techniques.  The Hermes 
antigen  isolated from both glial cells and fibroblasts- 
which express a predominant 90-kD form similar in 
relative molecular mass,  isoelectric point,  and protease 
sensitivity to lymphocyte gp90  n  ..... was able to bind 
purified MAd.  In contrast,  a  140-160-kD form of the 
Hermes antigen isolated from squamous epithelial 
cells lacked this capability.  Like lymphocyte binding to 
mucosal HEV, the interaction between glial gp90  H~ 
and MAd is inhibited by mAb Hermes-3, but not 
Hermes-I, suggesting that similar molecular domains 
are involved in the two binding events. The observa- 
tion that the Hermes/CD44 molecules derived from 
several nonlymphoid cell types display binding do- 
mains homologous to those of lymphocyte homing 
receptors suggests that these glycoproteins represent a 
novel type of cell adhesion/recognition  molecule 
(H-CAM) potentially mediating cell-cell or cell-ma- 
trix interactions  in multiple tissues. 
S 
PECIFIC cell-cell and cell-matrix adhesion is a funda- 
mental  property of multicellular  organisms,  account- 
ing,  at least in part,  for the development and main- 
tenance of specialized cellular form and function (for reviews 
see Edelman and Thiery, 1985; Jessell,  1988; Obrink,  1986). 
Although  a vast array of specific cellular recognition/adhe- 
sion events must occur during ontogeny, recent studies have 
revealed evolutionary  mechanisms  that would tend to reduce 
the total number of genes and polypeptides needed to medi- 
ate these interactions.  Foremost among these mechanisms  is 
the phenomenon that individual  or closely related  families 
of cell adhesion molecules (CAMs) ~  are expressed in a vari- 
ety of different  tissues and probably participate  in diverse 
cellular interactions  at these distinct anatomic  sites. For ex- 
1. Abbreviations  used in this paper: CAM, cell adhesion molecule; F-MAd, 
FITC-conjugated  mucosal vascular addressin; HEV, high endothelial ven- 
ules; HFF, human foreskin fibroblasts;  MAd, mucosal vascular addressin; 
TR, Texas red; TL, tonsil lymphocytes. 
ample, the neural cell adhesion molecule (N-CAM), the cad- 
herins,  the integrins,  and intercellular  adhesion molecule-1 
(ICAM-1) are all expressed by multiple and varied cell types 
of distinct histogenetic origin (Crossin et al., 1985; Hatta et 
al., 1987; Ruoslahti et al., 1985; Dustin et al., 1986). It fol- 
lows from these examples that molecules with demonstrated 
cell recognition/adhesion  activity in one setting are potential 
candidates  for homologous function  in different  settings. 
Our laboratory has previously characterized  a class of 90- 
kD human lymphocyte cell surface glycoproteins (defined by 
antibodies of the Hermes series) that is involved in the het- 
erotypic recognition  of high endothelial  venules (HEV), the 
specialized  venules in lymphoid organs and sites of chronic 
inflammation  that mediate lymphocyte extravasation  in the 
process of lymphocyte homing  (for reviews see Jalkanen  et 
al., 1986a; Berg et al., 1989). In general, lymphoid popula- 
tions lacking these glycoprotein  "homing receptors" are un- 
able  to  effectively  interact  with  HEV,  and  antibodies  to 
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binding (Jalkanen et al.,  1986b, 1987). One ligand for lym- 
phocyte homing receptors, a 58-66-kD protein expressed by 
HEV in mucosal lymphoid tissue (mucosal vascular addres- 
sin  [MAd]),  has  been  identified  (Streeter  et  al.,  1988a; 
Nakache  et al.,  1988),  and  specific,  saturable binding  of 
purified gp90  "e~s to purified MAd has been demonstrated 
with fluorescence energy transfer techniques (Nakache, M., 
E. L. Berg, L. J. Picker, and E. C. Butcher, manuscript sub- 
mitted for publication). 
We and others have recently demonstrated that the Hermes 
class of lymphocyte homing receptors are the same as, or 
include, the CD44 (In[Lu]-related p80) and human Pgp-1 an- 
tigens (Picker et al.,  1989) and the extracellular matrix re- 
ceptor III (Gallatin,  W.  M., E. Wayner, T. St. John,  E.  C. 
Butcher, and W. Carter,  manuscript  submitted for publica- 
tion), molecules which have been reported to be expressed 
on a variety of nonhematolymphoid cell types (Letarte et al., 
1985; Quackenbush et al., 1985, 1986; Daar and Fabre, 1981, 
1983; McKenzie et al., 1982; Isacke et al., 1986; Carter and 
Wayner,  1988). Here, using mAbs recognizing five distinct 
epitopes  on  lymphocyte gp90  H  .... ,  we confirm  the  wide- 
spread expression of molecules closely related to these lym- 
phocyte homing receptors. Most importantly, we demonstrate 
that  some of these  nonlymphoid  antigens  possess ligand- 
binding  sites homologous to those of lymphocyte homing 
receptors. These findings suggest that this class of glycopro- 
teins has broad functional significance,  perhaps  serving as 
CAMs in diverse settings. 
Materials and Methods 
Tissue and Cells 
Samples of snap-frozen normal human tissues for immunostaining were ob- 
tained from the Department of Pathology's frozen tissue bank at Stanford 
University (Stanford, CA). Tonsil lymphocytes (TL) were obtained by gen- 
tle mincing and washing of fresh human tonsil specimens over type 304 steel 
screen (Tylinter, Mentor, OH) in RPMI-1640 media. The collected TL were 
washed twice by centrifugation through RPMI-1640 media before prepara- 
tion of lysates (see below). The human glioma cell line HS683 (HTB138) 
was obtained from the American Type Culture Collection (Rockville, MD). 
Human foreskin fibroblasts (HFF) were a  kind girl of Dr.  M.  Bernfield 
(Stanford University, Stanford, CA), and were used as passage 6-8. Charac- 
teristics of the human keratinocyte cell line SCL-1  (derived from a human 
squamous cell carcinoma of the skin) and the human lymphoid cell line 
KCA have been described previously (Boukamp et al.,  1982;  Jalkanen et 
al.,  1986b,  1987). 
Antibodies and Immunostaining 
The isolation and characterization of mAbs of the Hermes series- Hermes-1 
(rat IgG2a), Hermes-2 (rat IgG2a), Hermes-3 (mouse IgG2a), H2-7 (mouse 
IgG1), and H3-51  (mouse IgG2b)-have been described previously (Jalka- 
nen et al., 1986b,  1987; Picker et al., 1989).  All of these mAbs recognize 
identical bands on Western blots of lymphoid cell lysates, and these bands 
are all entirely precleared with the Hermes-I mAb. Cross-blocking studies 
indicate that mAbs Hermes-l, -2, and -3 define sterically independent epi- 
topes. H2-7 and H3-51 are cross-blocked by Hermes-2 and -3, respectively, 
but have been determined to see different epitopes by other criteria (Gold- 
stein et  al.,  1989).  For example,  Hermes-3, but not H3-51,  recognizes 
Hermes antigen homologues on monkey, goat, and sheep lymphocytes. Fur- 
thermore, both H2-7 and H3-51  react with the fusion proteins from the re- 
cently isolated Hermes-specific eDNA clones 3`3A21 and 3,14-1 (3`gtll  ex- 
pression system). Hermes-3 reacts only with the 3`3A21 fusion protein, 
whereas Hermes-2 is nonreactive with both. The reactivity of H2-7, H3-51, 
and Hermes-3 with fusion proteins produced in a bacterial expression sys- 
tem indicate that the epitopes recognized by these antibodies are not depen- 
dent on normal human posttranslational processing. All antibodies were 
used under saturating conditions. Species- and isotype-matched mAbs of ir- 
relevant specificity were used as controls. 
Examination of the distribution of Hermes antigen in various tissues was 
done on acetone-fixed cryostat sections using both indirect immunofluores- 
cence (Haynes et al., 1982),  and a three-stage biotin-avidin immunoperoxi- 
dase technique (Bindl and Warnke, 1986). For some tissues (i.e., those with 
high backgrounds using the biotin-avidin system), these techniques were 
supplemented with a two-stage immunoperoxidase procedure, as previously 
described (Streeter et al., 1988a,b). For immunostaining of adherent tissue 
culture cells, cells were grown on tissue culture chamber slides (Miles 
Laboratories Inc., Naperville, IL) and stained unfixed by indirect immu- 
no  fluorescence. 
Antigen Preparation and Quantitation 
Lysates were prepared by incubating cells in lysis buffer (2% NP-40,  150 
mM NaCI,  1 mM MgCi2,  10/zg/ml Aprotinin, and  1 mM PMSF in 20 
mM Tris-HCl, pH 7.5) for 30 rain at room temperature. TL and KCA were 
lysed at 4  x  107 cells/ml. The adherent cell lines were lysed directly in the 
culture flasks (cultures at 80-90% confluence) after extensive rinsing with 
RPMI-1640 media using 5 ml lysis buffer per flask (Falcon T-175; Becton 
Dickinson Labware, Lincoln Park, NJ). Lysates were clarified by centrifu- 
gation (48,000  g  for 30 min at 4°C) followed by passage through 0.2-/~m 
filters (Nalge Co., Rochester, NY). Hermes antigens were isolated by pas- 
sage of the crude lysates over a  precolumn of normal  rat IgG (Cappel 
Laboratories, West Chester, PA) coupled to Sepharose 4B followed by a 
Hermes-l-Sepharose column (1.2-ml columns; 2 mg Ig/ml CNBr-activated 
Sepharose 41}; Pharmacia Fine Chemicals, Uppsala, Sweden). Columns 
were extensively washed with 20 mM Tris-HCl, pH 7.5, containing 500 mM 
NaCI,  1 mM MgCI2,  1 mM PMSE and 0.1%  NP-40 (wash buffer) and 
were eluted with 0.1% NP-40, 500 mM NaCI, and 1 mM PMSF in 200 mM 
acetic acid. The eluted fractions (0.8 ml) were neutralized with 0.25 ml of 
1 M Tris-HCl, pH 8, and were analyzed quantitatively for Hermes antigens 
by dot-blot analysis (1-#1 aliquots of serial dilutions of antigen preparations 
blotted on nitrocellulose and  examined as described below for Western 
blots) and, in some experiments, by a sandwich-type ELISA (Hermes-I as 
capture mAb and Hermes-3 as detection mAb; adapted from Staehelin et 
al., 1981). Antigen preparations to be used comparatively in a given experi- 
ment were quantified simultaneously, and the antigen concentration of each 
preparation was normalized by dilution to that of the least concentrated 
preparation. 
For IEF and peptide mapping experiments, the eluted fractions with the 
highest Hermes antigen concentration (and corresponding fractions of nor- 
mal rat IgG columns as controls) were labeled with 125I using chloramine- 
T-mediated iodination (Klinman and Taylor,  1969).  Labeled proteins were 
separated from free 125I by precipitation with Hermes-l-Sepharose (or, for 
controls, normal rat IgG-Sepharose) followed by extensive washing over 
10%/20% sucrose (in wash buffer) gradients and, finally,  resuspension of 
beads in wash buffer. 
For energy transfer experiments, Hermes antigens purified to near ho- 
mogeneity (see Fig. 4) were conjugated to Texas red (TR) using the method 
of Titus et al. (1982).  The unconjugated Hermes antigen preparations re- 
quired for these experiments were treated identically except that TR was 
omitted. MAd was purified from mouse mesenteric lymph node stroma as 
previously described (Streeter et al., 1988a;  Nakache et al., 1988) and con- 
jugated to FITC using the method of Goding (1976). Murine MAd is appro- 
priate for use in these experiments since lymphocyte-HEV interactions are 
not species specific, occurring with similar specificity and efficiency in 
xenogeneic and homologous combinations (Wu et al.,  1988). 
Electrophoretic Procedures and Western Blotting 
Aliquots of crude lysates or purified Hermes antigen preparations were ap- 
plied to 8% SDS-PAGE gels according to the method of Laemmli (1970). 
To preserve optimal antigenicity for Western blotting, samples were heated 
to 37°C for 15-30 min rather than boiling and gels were run under non- 
reducing conditions. Proteins were transferred to nitrocellulose with a trans- 
blot  apparatus  (Bio-Rad  Laboratories,  Richmond,  CA).  After blocking 
nonspecific protein binding with 100%  horse serum for 30 min, primary 
and secondary antibody incubations (alkaline phosphatase-conjugated anti- 
rat IgG [Sigma Chemical Co., St. Louis, MO] or anti-mouse IgG [Promega 
Biotec, Madison, WI]) were done in a staining apparatus (Miniblotter 25; 
Immunetics, Cambridge, MA; for 1 h each). The alkaline pbosphatase reac- 
tion was developed as described in the 3`-gtll  screening kit (Promega Bio- 
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SDS-PAGE gels under reducing conditions. Gels were fixed and stained per 
instructions of a silver stain kit (Bio-Rad Laboratories). 
Slab gel IEF was done according to the method of Neefjes et al. (1986) 
using purified  12~I-labeled Hermes antigens (,x,0.5  x  106 cpmllane).  A 
standard surface electrode was used to measure the pH gradient formed in 
the gels. A  ratio of ampholines (Pharmacia Fine Chemicals) of 50%  pH 
4-6.5, 33% pH 3-10, and 17% pH 3-5 gave the desired 4-7 pH gradient. 
Two-dimensional gel electrophoresis (IEF followed by  SDS-PAGE) was 
performed as described by O'Farrell (1975). 
Peptide mapping was done according to the method of Cleveland et al. 
(1977).  The 12SI-labeled antigen preparations (,x,0.5  ×  106 cpm/lane) were 
first run on preparative SDS-PAGE (8%, reducing conditions). These gels 
were dried unfixed, the desired bands were excised, and the gel slices were 
rehydrated before application to the Cleveland gels (12.5%). After the dye 
front was two thirds of the way through the stacking gel, the current was 
turned off and protease digestion using bovine pancreas trypsin (Sigma 
Chemical Co.; 7-30/~g/well in different experiments) or Staphylococcal V8 
protease (Boehringer Mannheim GMB, Mannheim, FRG;  10-50 teg/well) 
was allowed to proceed for 40 min before the completion of the electropho- 
resis. Both IEF two-dimensional and Cleveland gels were fixed in 40% 
methanol,  10%  acetic acid in distilled water, dried, and then exposed to 
X-OMAT AR film (Eastman Kodak Co., Rochester, NY) with an intensify- 
ing screen. 
Hermes Antigen-MAd Binding Assay 
Binding of Hermes antigens from different cell types to MAd was assessed 
using a technique based on the nonradiative transfer of fluorescence energy 
between closely associated fluorophores (Epe et al.,  1983;  Stryer,  1978, 
Nakache, M., E. L. Berg, L. J. Picker, and E. C. Butcher, manuscript sub- 
mitred for publication). In this technique, the purified proteins to be as- 
sessed for binding interaction are conjugated to FITC (e.g., F-MAd) and to 
TR (e.g., TR-Hermes antigen), respectively. Under excitation at 493 nm, 
the FITC conjugate will give a characteristic emission spectrum peaking at 
",,517 nm. Little or no emission is detected at 615 nm, the TR emission peak. 
If the proteins being tested do not interact, addition of the TR-conjugated 
species will not materially affect the FITC emission spectrum. On the other 
hand, if the FITC and TR conjugates do bind (i.e., approach to within *70 
or less/~ of each other), nonradiative (Forster) energy transfer will occur 
between the two fluorochromes (i.e., from FITC to TR).  In this circum- 
stance, the 517-rim emission of FITC will decrease (i.e., be quenched) and 
a 615-nm TR emission will appear. 
We have defined a  binding parameter 6 which serves to quantitate the 
quenching of the 517-nm fluorescent emission due to energy transfer and to 
control for perturbations of the emission intensity due to conformational or 
electrostatic alterations associated with the addition of test or control solu- 
tions. The binding parameter 
6  =  (Fo  -  Fq)/Fo, 
where Fq and Fo represent the 517-nm emission after addition of a given 
amount of  TR-Hermes antigen or an equal amount of unconjugated Hermes 
antigen, respectively. In other words, 6 represents the fractional decrease 
in the 517-nm FITC emission due to the presence of the quencher/acceptor 
fluorophore (TR) on the Hermes antigen in complex with F-MAd. Thus, 
in these experiments, increasing amounts of the TR-labeled Hermes antigen 
preparations (~90 td) were added to 200-/,d aliquots of the F-MAd prepara- 
tions, and the 517-nm emission was measured at 20"C on a fluorolog instru- 
ment (model 2000; Spectra-Physics, Inc., Mountain View, CA) with a spec- 
tral band width of 8 nm (493 nm excitation wavelength) aP,  er each addition 
(Fq).  In parallel,  similar measurements were made after the addition of 
equivalent amounts of unconjugated Hermes antigen to aliquots of the same 
F-MAd preparations (/7o). 
For experiments assessing reversibility of gp90Xe"e~-MAd complexes, 
energy transfer was initially established with F-MAd and saturating amounts 
of KCA  Hermes  antigens  (TR-labeled  vs.  unconjugated,  as  described 
above). The reaction mixtures were divided into five aliquots, and to each 
aliquot increasing amounts of unconjngated Hermes antigens from the five 
different cell types (equal amounts to cuvettes with TR-labeled and uncon- 
jugated KCA Hermes antigens) were added. The ~ parameter was deter- 
mined after each addition of unconjugated Hermes antigen. For antibody 
blocking experiments, 15 p.g of Hermes-3, Hermes-I, or a class-matched 
mAb control for Hermes-3 was added to  150 /~l of the Hermes antigen 
preparations (both TR-laheled and unconjngated) and allowed to incubate 
for 5-10 rain before addition to F-MAd and calculation of ~5 as described 
Table 1. Distribution of  Hermes Antigen in 
Nonhematolymphoid Human l~ssues 
Tissue type  Reactivity* 
Epithelium/parenchymal organs 
Skin 
Epidermis  + 
Sweat glands/pilosebaceous structures  + 
Gastrointestinal tract 
Buccal/esophageal mucosa  + 
Gastric/small and large intestinal mucosa  +t 
Pancreatic ducts/acini  + 




Kupffer cells  + 
Kidney 
Bowman's capsule epithelium 
Tubular epithelium 
Mesangial cells  + 
Lung 
Bronchial epithelium  -l- 




Ducts and acini  + 
Uterus 
Endometrial glands  + 
Ovary 





Glands  + 
Endocrine glands 
Thyroid follicular cells  + 
Adrenal cortex 
Adrenal medulla  ÷ 
Mesenchymal tissues 
Fibroblasts  + 
Smooth muscle 
non-vascular  + 
vascular  +  (Variable) 
Endothelium 
Skeletal muscle 
myocytes  :1: 
endomysial cells  + 
Nervous system 
Central 
gila  +  (Variable) 
neurons 
Peripheral 
Schwann cells  +  (Variable) 
* Reactivity  with  Hermes-l, -2,  and -3;  H2-7;  and H3-51 antibodies:  (+) 
clear, unequivocal  staining;  (+) weak or equivocal  staining;  and (-) lack of 
reactivity  above background. 
Staining  is  strongest at  base of crypts and decreases towards superficial 
mucosa. 
above. Characterization of MAd interaction with KCA and TL gpgO  Her~ 
by energy transfer has been previously reported (Nakache, M., E. L. Berg, 
L. J. Picker, and E. C. Buteher, manuscript submitted for publication) and 
is recapitulated in this report for purposes of comparison. 
Picker et al. H-CAM: A  Novel Class of Cell Adhesion  Molecule  929 Figure 1. Distribution of Hermes antigen in normal human tissues (immunoperoxidase  with methylene blue counterstain).  (a) Skin section 
showing strong reactivity  with epidermis (excluding stratum corneum) and dermal fibroblasts.  A positive eccrine duct is present in the 
lower left corner.  (b) Salivary gland section showing positive acini (upper half), a longitudinally  sectioned duct (lower half', note that the 
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Expression of  Hermes Antigen in Normal 
Human Tissues 
Immunohistologic  examination  of normal,  nonhematolym- 
phoid human tissues showed widespread expression of Her- 
mes antigen (summarized in Table I). Five different mAbs, 
each to a distinct epitope on the lymphocyte gp90 molecules 
(including  three antibodies whose epitopes are not depen- 
dent on posttranslational processing) were used in this study 
to rule out cross-reactivity with unrelated proteins. The dif- 
ferent Hermes antibodies varied in staining intensity, but all 
showed the same pattern of reactivity in all tissues examined. 
Squamous epithelia, both nonkeratinizing and keratinizing 
(Fig.  1 a),  and most glandular  epithelia  (Fig.  1,  b  and c) 
showed strong expression of Hermes antigen. Some special- 
ized epithelial ceils, such as renal tubular cells (Fig. 1 d) and 
hepatocytes (Fig.  1 e),  lacked Hermes antigen expression 
while others, such as thyroid follicular cells (Fig.  1  f), were 
positive.  In general,  staining  was most intense in the ger- 
minative region of the epithelium (e.g., crypts of intestinal 
mucosa), and in simple ductal epithelium staining was often 
most intense abluminally and at the lateral cell borders (Fig. 
I  b). 
Among  mesenchymal  cells,  fibrohlasts  and  nonvascular 
smooth  muscle cells appeared  uniformly  Hermes  antigen 
positive (Fig.  1, a-d). Hermes antigen expression in vascu- 
lar smooth muscle was variable with some vessels-partic- 
ularly  in  the  pulmonary  circulation-showing  little  or no 
reactivity,  while other vessels were strongly positive.  En- 
dothelium  lacked  reactivity,  and  staining  of skeletal  and 
cardiac muscle was either negative or equivocal. 
In the central nervous system, a subset ofglial cells, partic- 
ularly fibrous astrocytes, were strongly Hermes antigen posi- 
tive,  whereas  neurons  and  their processes appeared  to be 
negative (Fig.  1, g-i).  Staining  was particularly  intense in 
white matter  (especially perivascular  astrocytes;  Fig.  1, g 
and i), subpial astrocytes, the granule cell layer in the cere- 
bellum (Fig. 1 i), and the spinal cord grey matter (especially 
anterior horn; Fig. 1 h). Normal cortical glia were negative, 
whereas relatively fainter staining was observed in deep grey 
structures.  In  the  peripheral  nervous  system,  a  subset of 
Schwann cells was intensely Hermes antigen positive. 
Consistent with the observed patterns of reactivity in tis- 
sue sections, HFF, the squamous epithelial cell line SCL-1, 
and the glioma cell line HS-683 showed cell surface reactiv- 
ity with Hermes-3 (Fig. 2) as well as the other mAbs of the 
Hermes series (not shown). The lymphoid cell line KCA also 
demonstrated  surface staining with all Hermes mAbs (not 
shown). These cell lines were used as sources of cell type- 
specific Hermes antigen for the biochemical and functional 
studies discussed below. 
Biochemical Characterization of  Hermes 
Glycoproteins of  Distinct 7issue Origin 
Western blot analyses of crude lysates from human glioma 
cell  line  HS683,  squamous  epithelial  cell  line  SCL-1,  in 
vitro-passaged  foreskin  fibroblasts  (HFF),  lymphoid  cell 
line KCA, and TL were used initially to compare the molecu- 
lar properties of Hermes antigen derived from distinct cell 
types (Fig. 3). Using the Hermes-3 mAb on blots of HS683, 
HFE KCA, and TL lysates, we demonstrated the presence 
of a major specific band in the 75-95-kD region (nonreduc- 
ing conditions). In contrast to the aforementioned cell types, 
the  squamous  epithelial  cell  line  SCL-1  showed a  major 
broad band in the 140--190-kD region and only a very faint 
band at 80-90 kD.  MAbs Hermes-l,  Hermes-2,  H2-7,  and 
H3-51 gave similar results (not shown). 
The Hermes-3 antibody was also used to probe Western 
blots of affinity-isolated Hermes antigens  (Fig.  4).  Again, 
HS683, HFE and KCA demonstrated a major broad band in 
the  75-90-kD  region.  However,  with  the purified  antigen 
preparations,  a faint 210-220-kD band, which was not dis- 
cernable in the analysis of crude lysates, was also identified 
in these cell types. The major SCL-1 band was at 140-160 
kD and was clearly distinct from the 210-200-kD form. A 
faint band was discernable  in the 80-90-kD  region of the 
purified SCL-1 Hermes antigen preparations (similar to the 
major species of the other cell types). The trail-off of Her- 
rues-3 reactivity in the 90-200-kD and 160-190-kD regions 
of the HS683 and SCL-1 crude lysates, respectively (Fig. 3), 
is probably due to incomplete reaction of the high protein 
crude lysates with SDS under the gentle reaction conditions 
used  (purified  antigen  lacked  most  of this  reactivity;  cf. 
Fig. 4). 
To further  compare  the  molecular  structure  of Hermes 
glycoproteins from these different cell types, the purified an- 
tigen preparations  were labeled with  '25I and  subjected to 
slab gel  IEF.  As  shown  in  Fig.  5,  Hermes  antigen  from 
HS683, HFF, KCA, and TL focused similarly (pI '~5.8). The 
210-220-kD form does not iodinate efficiently and is not seen 
in these gels. The squamous epithelial cell line SCL-1 showed 
two bands after focusing-a minor band that comigrates with 
the Hermes antigens in the other cell types and a major, more 
basic band (pI ,~6.1).  Two-dimensional gels (IEF followed 
by SDS-PAGE) confirmed that the more basic species corre- 
reactivity is restricted to abluminal and lateral aspects of the epithelial cells), and fibroblasts (lower half, adjacent to duct). (c) Section 
of uterus showing positive endometrial glands and stroma (upper half) and positive smooth muscle cells in the myometrium (Myom.). 
(d) Kidney section showing Hermes reactivity in mesangial cells within the glomerulus and in interstitial fibroblasts; Bowman's capsule 
epithelial cells and tubular epithelial cells (arrows) are negative. (e) Liver section showing reactivity in portal fibmblasts and scattered 
Kuppfer cells within the hepatic lobule. Hepatocytes and bile duct epithelium (arrow) are negative. (f) Section of thyroid demonstrating 
strong staining of thyroid follicles. (g) Section of brain demonstrating extensive reactivity in subeortical white matter (note perivascular 
enhancement) and lack of reactivity in neocortex. (h) Section of spinal cord showing strong positivity of both white matter (lower half) 
and anterior horn grey matter (upper half). (i) Section of cerebellum showing Hermes reactivity in White matter (lower  third; again note 
perivascular accentuation) and granular cell layer (middle third; granular layer neurons and Purkinje cells [arrow] appear negative; positiv- 
ity is attributable to interspersed gila) and lack of reactivity in molecular layer (upper third). Bar: (a-f and i) 60/~m;  (g) 120/~m; (h) 
200 ~m. 
Picker et al. H-CAM: A Novel Class of Cell Adhesion Molecule  931 Figure 2. Demonstration by immunofluorescence of cell surface Hermes-3 reactivity on (a) the squamous epithelial cell line SCL-I; (b) 
HFF; and (c) glial cell line HS683. Bar, 20 #m. 
sponds  to the  140-160-kD polypeptide and that the more 
acidic species corresponds to the 80-90-kD polypeptide (not 
shown). 
The biochemical similarity of the 75-90-kD Hermes anti- 
gens from all the different cell types was substantiated by 
peptide  mapping  using  the  technique of Cleveland et  al. 
Figure 3.  Western blot analysis of crude lysates with Hermes-3 
(right lane each column) vs. class-matched control (left lane each 
column). HS683 (column 1), HFF (column 2), TL (column 4), and 
KCA (column 5) show predominant specific bands in the 75-90-kD 
region, whereas SCL-I (column 3) shows only a faint band in this 
region and a major specific band at 140-190 kD (8% SDS-PAGE, 
nonreducing). A nonspecific band in the 220-kD region of the gel 
is present in the TL lysates (column 4). 
(1977) (Fig. 6). Preparative SDS-PAGE was used to isolate 
each band before analysis. All of the 75-90-kD species, in- 
cluding the minor SCL-1 80-90-kD band, yielded identical 
degradation products after digestion  with  V8  protease or 
trypsin. V8 protease treatment resulted in a major 25-30-kD 
degradation product,  whereas  the  major tryptic fragment 
was 40 kD. The 140-160-kD major SCL-1 band, when tested 
under identical conditions,  appeared much more protease 
resistant  than  the  lower molecular mass  species.  Trypsin 
failed to cleave this high molecular mass squamous epithelial 
band under the condition tested.  V8  protease cleaved this 
species less efficiently  than the 75-90-kD antigen, but did re- 
sult in an identical 25-30-kD degradation product, suggest- 
ing some degree of molecular homology with the lower mo- 
lecular mass form. 
Functional Comparison of Hermes Glycoproteins 
from Different Cell 7)pes 
We have previously shown a specific binding interaction be- 
tween isolated MAd and KCA-derived Hermes glycoproteins 
using a technique based on the nonradiative transfer of elec- 
tronic energy between donor and  acceptor fluorochromes 
(Nakache, M., E. L. Berg, L. J. Picker, and E. C. Butcher, 
manuscript submitted for publication). To ask whether the 
Hermes antigens from nonlymphoid cell types were func- 
tionally, as well as structurally, homologous to lymphocyte 
homing receptors, we assessed their capacity to interact with 
MAd.  As  shown in Fig.  7,  Hermes antigen derived from 
HS683 and HFF (predominantly 75-90 kD) did indeed bind 
MAd, whereas SCL-1 Hermes antigen (predominantly 140- 
160 kD) demonstrated little, if any, interaction. Interestingly, 
glial-  and  lymphocyte-derived Hermes molecules showed 
plateau 5 values in the same range, whereas Hermes antigen 
isolated from fibroblasts demonstrated a considerably lower 
maximum & These differences were not due to variation in 
the TR-labeling of the different Hermes preparations since 
reversal experiments, in which preformed MAd-HermesKc^ 
complexes  were  competitively  disrupted  with  increasing 
amounts of unconjugated Hermes antigen from the different 
cell types, showed generally similar results (Fig. 8). Further- 
more, the differences in the binding characteristics of Her- 
mes antigens of different cellular origin were observed with 
two independent preparations of Hermes antigen from each 
cell type. 
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PAGE gels  (10%, reducing)  of 
isolated  Hermes  antigens from 
HS683 (lane 1),  HFF (lane 2), 
SCL-1 (lane 3), TL (lane 4), and 
KCA (lane 5) showing purity of 
these  preparations.  Lane  6  is  a 
representative eluate (correspond- 
ing to peak fractions of specific 
columns) from control antibody 
(normal rat IgG) precolumn. (b) 
Western blot analysis of purified 
Hermes  preparations  with  Her- 
mes-3 (right  lane  each  column) 
vs.  class-matched  control  anti- 
body  (left  lane  each  column). 
HS683  (column  1),  HFF  (col- 
umn 2), and TL (column 4) show 
major 75-90-kD  and faint 210- 
220-kD  specific bands. In con- 
trast, SCL-1 (column 3) shows a 
faint 75-90-kD and a major 140- 
160-kD specific band (8% SDS- 
PAGE, nonreducing). 
Lymphocyte binding  to  mucosal  HEV  and  lymphocyte 
gp90  e  ..... binding to isolated MAd is blocked by the Her- 
mes-3 antibody (Jalkanen et al.,  1987; Nakache, M., E. L. 
Berg, L. J. Picker, and E. C. Butcher, manuscript submitted 
for publication). In contrast, the Hermes-1 antibody, which 
recognizes a  distinct epitope on gp90  a .... , does not block 
lymphocyte binding  to  HEV  of any  specificity (Jalkanen 
et al.,  1986b)  and  shows  only limited ability to  interfere 
with  lymphocyte gp90  H  .....  MAd  interaction as  measured 
by energy transfer (Nakache, M., E. L. Berg, L. J. Picker, 
and E.  C.  Butcher, manuscript submitted for publication). 
Figure 5. IEF gel of isolated Her- 
mes molecules  from KCA (lane 1), 
HS683  (lane 2),  HFF (lane 3), 
SCL-I  (lane  4),  and  TL  (lane 
5). The 75-90-kD molecules  show 
identical isoelectric  points, where- 
as the major  140-160-kD SCL-I 
is slightly more basic. The nar- 
row bands seen near the bottom of 
the gel in lanes 1 and 2 represent 
acidic  spontaneous  breakdown 
products noted to occur in some 
preparations with time. 
As  shown  in  Fig.  9,  analogous  results  are observed with 
HS683  (glial)-derived gp90  H  .... .  Hermes-3,  but not Her- 
mes-1  or an isotype-matched nonbinding control antibody, 
blocked  the  interaction  between  HS683  Hermes  antigen 
and MAd. 
Discussion 
The Hermes-defined lymphocyte cell surface glycoproteins 
have been designated lymphocyte homing receptors on the 
basis of their role in lymphocyte recognition of HEV. The 
participation of this class of molecules in lymphocyte HEV 
recognition and lymphocyte homing is supported by several 
lines  of experimental evidence.  First,  lymphoid cell lines 
lacking these glycoproteins generally bind HEV poorly or 
not at all (Jalkanen et al.,  1986a,b).  Second, antibodies re- 
active with this class of  molecules can block binding to HEV. 
For example, mAb Hermes-3 blocks lymphocyte binding to 
mucosal HEV, and polyclonal anti-Hermes-1 antigen antise- 
rum blocks lymphocyte binding to all HEV types (Jalkanen 
et al.,  1987).  Third,  as described above, purified Hermes 
molecules from TL and the mucosal HEV-specific cell line 
KCA specifically bind the high endothelial cell surface pro- 
tein MAd (Nakache, M., E. L. Berg, L. J. Picker, and E. C. 
Butcher, manuscript submitted for publication). While these 
data establish that Hermes glycoproteins are involved in lym- 
phocyte recognition of HEV, the results presented in this re- 
port suggest this class of molecules may have much broader 
functional significance, perhaps constituting a novel family 
of primary CAMs. 
Our finding that glycoproteins closely related to lympho- 
cyte homing receptors are widely expressed in the human 
body (including cells derived from all three primary germ 
layers) confirm and extend previous observations showing 
CD44 antigen expression in normal brain,  kidney, breast, 
and colon, as well as a variety of cell lines and tumors de- 
Picker et al. H-CAM: A Novel Class of Cell Adhesion Molecule  933 Figure 6. Cleveland gels of isolated Hermes 75-90-kD molecules derived from KCA (lane 1 ), HS683 (lane 2), SCL-I (lane 3), HFF (lane 
5), and TL (lane 6) and of the isolated 140-160-kD SCL-I species (lane 4). (a) Without added protease; (b and c) contained 30 ~g/well 
V8 protease and 50/~g/well trypsin, respectively. All species yielded a major V8 degradation product of 25-30 kD, whereas only the 75-90- 
kD forms showed the 40-kD trypsin degradation product. The 40-kD tryptic fragment was not observed in the lane with the 140-160-kD 
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Figure  7.  Direct  assessment  of  MAd  binding  by 
Hermes antigen isolated from the KCA lymphoid cell 
line ([]), TL (m), HS683 glial cell line (X), HFF (,x), 
and SCL-I squamous epithelial cell line (A). Increas- 
ing amounts of Hermes antigen (unlabeled vs. TR con- 
jugated) were added to identical solutions of F-MAd. 
All Hermes antigen preparations were at equivalent 
antigen concentrations.  6,  a  quantitative parameter 
related to the energy transfer-associated quenching of 
the 517-rim FITC emission due to binding of TR-la- 
beled gp90 to F-MAd (see text),  is plotted vs.  the 
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Figure 8.  Reversal of preformed KCA Hermes anti- 
gen-MAd complexes by Hermes antigens of different 
origin. Plateau binding was established with g~ 
from the KCA lymphoid cell line (unlabeled vs.  TR 
conjugated) as shown in Fig. 7. The reaction mixture 
was aliquoted and then increasing amounts of unla- 
beled Hermes antigen from the KCA cell line (E3), TL 
(m), HS683 glial cell line (X), HFF (zx), and SCL-1 
squamous  epithelial cell line  (a)  were  added.  All 
Hermes antigen preparations were at equivalent anti- 
gen concentration. Results are presented as 6 vs. the 
amount of competing unlabeled Hermes antigen add- 
ed (arbitrary units). 
The Journal of Cell Biology,  Volume 109, 1989  934 0.3 
0.2  I 
0.1 
0.0  T  ,  ,  !  , 
0  10  20  30  40 
! 
50 
amount Hermes Ag added 
! 
60 
Figure 9.  Antibody inhibition of the binding of glial 
gp90  Ne~'~ to MAd. Hermes-3 (i), but not a class- 
matched nonbinding  control antibody (n) or Hermes- 
1 (X), block fluorescence  energy transfer when added 
to the glial gp90  ae"~s preparations before incubation 
with F-MAd. Results  are presented as ~ vs. the amount 
of Hermes antigen (with antibody) added (arbitrary 
units). 
rived from these and other sites (Letarte et al., 1985; Quack- 
enbush et al.,  1985, 1986;  Daar and Fabre,  1981, 1983; 
McKenzie et al., 1982). Our study shows considerably more 
expression of the Hermes/CD44 antigen in central nervous 
system grey matter (e.g., spinal cord grey matter) than previ- 
ously appreciated, as well as documenting expression in pre- 
viously  unreported  sites  (Table  I).  Five  distinct homing 
receptor epitopes, including three that are not dependent on 
eukaryotic posttranslational processing, are coexpressed at 
all positive tissue sites, strongly suggesting that this broad 
distribution is not due to cross-reactivity of  carbohydrate epi- 
topes on dissimilar glycoproteins, as has been reported for 
the HNK-1/L2 and L3 antigens (Kruse et al., 1984; Kucherer 
et al.,  1987). 
Biochemical studies of Hermes antigens derived from dis- 
parate cell types also indicate that these various Hermes mol- 
ecules are closely related. Three structurally distinct species 
of Hermes antigen were defined: 75-90,  140-160,  and 210- 
220 kD. In a recent study using the CD44 mAb 50B4 and 
the Pgp-l-specific mAb El/2, Omary et al. (1988)  showed 
three  probably  analogous  molecular  species  variably  ex- 
pressed on lymphoid, epithelial, and fibroblast cell lines, but 
did not further compare these molecules. In our comparison 
of  these various species, we found that the 75-90-kD Hermes 
antigen (the major form of Hermes antigen on lymphoid 
cells, glial cells, and fibroblasts) from all the cell types exam- 
ined had identical isoelectric points and peptide maps, con- 
sistent with strong  structural  homology, or perhaps  even 
identity (see below), between these species. Lymphoid cells, 
glial cells, and fibroblasts also possessed a minor 210-220- 
kD Hermes antigen species,  which in lymphoid cells has 
previously been shown to be a chondroitin-sulfate-modified 
form that appears  to share a  common precursor with the 
75-90-kD  species (Jalkanen et al.,  1988).  The major Her- 
mes antigen in the squamous epithelial cell line SCL-1 was 
140-160 kD, showed a more basic isoelectric point, and was 
resistant to trypsin. This 140-160-kD species did, however, 
express multiple Hermes epitopes and shared a common V8 
protease degradation product with the 75-90-kD form, sug- 
gesting considerable structural homology between the two 
species. Chondroitinase, heparinase, and keratinase did not 
affect the  140-160-kD  SCL-1  antigen, and digestion with 
O-glyeanase, N-glycanase, and neuraminidase, in combina- 
tion and alone, showed relatively small effects,  insufficient 
to account for the molecular mass difference with the 75-90- 
kD species (Picker, L., unpublished observations). Further- 
more, pulse--chase experiments with radiolabeled methionine 
indicate that the earliest, lowest molecular mass Hermes an- 
tigen precursor  from  SCL-1  squamous epithelial cells  is 
15-20 kD larger than that of the other cell types (Uksila, J., 
and L. Picker, unpublished observations). Thus, while the 
exact nature of the structural differences between gp90  He"~ 
and gpl50  H°~'~ is unclear, the larger size of gpl50  a~"~'~ must, 
at least in part, be due to additional primary sequence and/or 
to early posttranslational modifications that are not affected 
by the glycolytic enzymes described above. 
These serologic and biochemical comparisons indicate a 
close structural relationship between the Hermes/CD44 an- 
tigens on diverse cell  types,  but do  not directly address 
whether these antigens are functionally homologous as well. 
To examine this question, we took advantage of one known 
function of the Hermes class of lymphocyte homing recep- 
tor-its  ability to  bind  MAd,  an endothelial cell  surface 
adhesion molecule for lymphocytes that directs lymphocyte 
homing to mucosal lymphoid tissues (Streeter et al., 1988a; 
Nakache et al., 1988; Nakache, M., E. L. Berg, L. J. Picker, 
and E.  C. Butcher, manuscript submitted for publication). 
We found that isolated Hermes glycoproteins from such dis- 
parate cell types as fibroblasts and glial cells were able to 
bind MAd, whereas the structurally distinct squamous epi- 
thelial Hermes antigen lacked this binding activity. The abil- 
ity of mAb Hermes-3, but not Hermes-I, to block the glial 
gp90  H  ..... MAd interaction (the  same pattern of antibody 
inhibition seen for lymphocyte binding to mucosal HEV and 
direct lymphoid gp90 "~  .....  MAd interaction) suggests that 
MAd binding by lymphoid and nonlymphoid gp90  H~s is 
mediated  by  similar  binding  domains.  The  inability  of 
gpl50  H~"~ to interact with MAd suggests that this binding 
domain is either absent or blocked in this higher molecular 
mass form. It is also important to note that the binding curves 
of the 75-90-kD Hermes antigens from lymphoid cells, glia, 
and fibroblasts to MAd were reproducibly different. This ob- 
servation raises the possibility that functionally important 
structural differences exist between the 75-90-kD  Hermes 
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biochemical analyses. In other systems, subtle structural al- 
terations (e.g., single amino acid substitutions) have shown 
to dramatically alter binding specificities of proteins (Rogers 
et al.,  1983;  Mellins et al.,  1988). 
The specific interaction between MAd and nonlymphoid 
Hermes glycoproteins is not likely of physiologic signifi- 
cance per se, since MAd expression is largely limited to post- 
capillary venules in mucosal tissues (Streeter et al., 1988a). 
However,  the ability of diverse gp90  ae"~s to interact with 
MAd implies that they too may be adhesion molecules, per- 
haps recognizing ligands homologous to MAd. In this con- 
text, it is interesting that rat lymphocytes specifically bind to 
white matter tracts in the rat brain in a manner that mimics 
lymphocyte binding to HEV (similar specificity for thoracic 
duct lymphocytes vs.  thymocytes, similar temperature de- 
pendence,  etc.;  Kuttner and Woodruff,  1979).  Given our 
present demonstration of high levels  of gp90  H  .... in white 
matter tracts and the remarkable ability of glial gp90  "e~s to 
interact with a homing receptor ligand, such binding of lym- 
phocytes to myelinated tracts could be mediated by cross-re- 
active binding of rat gp90 homing receptors to a native ligand 
for glial gp90 in white matter. 
Ligands for nonlymphoid Hermes glycoproteins need not 
structurally resemble MAd to any great degree. For example, 
gp90  ae~s has been implicated in lymphocyte recognition of 
peripheral  lymph node HEV (Jalkanen et al.,  1987).  Al- 
though not yet formally proven,  the  putative endothelial 
ligand for this binding interaction is the peripheral lymph 
node addressin (Streeter et al., 1988b;  Streeter,  P. R., L. J. 
Picker, S. A. Michie, and E. C. Butcher, manuscript in prep- 
aration), a 90-kD glycoprotein with structural characteris- 
tics distinct from MAd (Berg et al.,  1989). 
As mentioned above,  we have recently demonstrated that 
the Hermes, CD44 (In[Lu]-related p80), and human Pgp-1 
antigens  are  similar  or  perhaps  identical  (Picker  et  al., 
1989),  and Gallatin, W. M., E. Wayner, T. St. John, E. C. 
Butcher, and W. Carter (manuscript submitted for publica- 
tion) have recently suggested close homology or identity be- 
tween these molecules and the extracellular matrix receptor 
III described by Carter and Wayner (1988).  No function has 
previously been attributed to CD44 and human Pgp-1; how- 
ever,  the extracellular matrix receptor III has been impli- 
cated in the adhesion of fibroblasts to extracellular matrix 
components including collagen (Carter and Wayner,  1988). 
Furthermore, preliminary studies suggest that the lympho- 
cyte Hermes antigen can interact with fibronectin and col- 
lagen (Jalkanen, S., personal communication). These obser- 
vations  suggest  that  gp90  He"~s may have  several  binding 
specificities, perhaps mediated by distinct binding domains. 
In this context, it is of interest that N-CAM, the prototypical 
primary CAM, has two binding activities mediated by dis- 
tinct domains on the  N-CAM  molecule(s):  a  homophilic 
binding site responsible for cell-cell interaction and a hep- 
arin-sulfate-binding site, presumably mediating extracellu- 
lar matrix binding (Cole and Glaser,  1986).  Furthermore, 
recent sequence analysis of gp90"~ encoding cDNAs from 
KCA has revealed a striking homology to domains in carti- 
lage proteoglycan core and link proteins (Goldstein et al., 
1989) that may interact bifunctionally with hyaluronic acid 
and protein (Neame et al.,  1987; Goetinck et al.,  1987). 
The Hermes antigens, like other primary adhesion mole- 
cules (Crossin et al., 1985; Hatta et al., 1987), also appear 
to be dynamically  expressed during development. For exam- 
ple, in a separate immunohistologic study of the developing 
human central nervous system, we have identified Hermes 
antigen expression on radial glia in the germinal matrix of 
fetal brains and have noted that the appearance of Hermes an- 
tigen expression in central nervous system white matter ap- 
pears to precede or accompany the process of myelination 
(Vogel, H., L. Picker, and E. Butcher, manuscript in prepa- 
ration).  McKenzie et al.  (1982)  have also  noted that the 
amount of CIM4 antigen markedly increases in brain during 
development. 
Taken together, these data strongly suggest that the Her- 
mes-defined cell surface molecules constitute a closely re- 
lated family of CAMs, likely involved in diverse cell-cell or 
cell-matrix interactions in cooperation with other cell adhe- 
sion systems. Given that one of the first reported adhesion/ 
recognition functions for these glycoproteins was in the pro- 
cess of lymphocyte homing, we have designated these mole- 
cules homing-CAMs (H-CAM). In the case of lymphocyte- 
HEV interaction there is increasing evidence that a number 
of distinct CAMs act in concert to control the specificity of 
lymphocyte homing (Berg et al., 1989).  However, as shown 
in this report, Hermes-defined H-CAMs appear functionally 
heterogenous, and this heterogeneity could also contribute to 
or reflect specificity of function in diverse cell-cell or cell- 
matrix interactions. The molecular basis of H-CAM hetero- 
geneity is largely unexplained, but in this regard studies of 
genomic DNA with the recently isolated H-CAM encoding 
cDNAs are compatible with one, or at most two, H-CAM 
genes (Goldstein et al., 1989). This observation suggests that 
H-CAM  structural  and  functional heterogeneity is  likely 
generated either by alternative RNA processing or by differ- 
ential posttranslational modification, processes previously 
demonstrated to be important in generating functional vari- 
ants of other CAMs (Cunningham et al., 1987; Hoffman and 
Edelman,  1983;  Rougon et al.,  1982).  Additional studies 
will be required to define in detail the role or roles of the 
H-CAM molecular family in the development and function 
of nonlymphoid tissues. 
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